GlassScriptPhysician profile
Stephen R Cullen
NPI 1679838387
$3,597.22
in general payments reported to CMS, 2019-2025
15 companies · $773 in 2025
The $773 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $466 · 2023: $1,096 · 2024: $1,152 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.40 |
| Education | $294.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,173.00 | 2021-2025 | Tremfya, Remicade, Simponi |
| Abbvie INC. | $847.86 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $330.42 | 2023-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $301.41 | 2023-2024 | Sotyktu |
| Genzyme Corporation | $179.31 | 2022-2024 | |
| Incyte Corporation | $169.72 | 2022-2024 | Opzelura |
| Dermavant Sciences, INC. | $136.81 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $115.52 | 2024-2025 | |
| Amgen INC. | $114.58 | 2021-2025 | Otezla, Otezla |
| Leo Pharma INC. | $74.97 | 2022-2023 | Adbry |
| Ucb, INC. | $58.85 | 2024 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.85 | 2023 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.40 | 2025 | Cabtreo |
| Ani Pharmaceuticals, INC. | $21.24 | 2024 | Purified Cortrophin Gel |
| Strata Skin Sciences, INC. | $16.28 | 2024 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.